SCHEMBL10253178

SCHEMBL10253178

CCOC(=O)/C(C)=C/c1ccc(CC)o1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.43
TP53 P04637 3/20 0.43
THRB P10828 1/20 0.42
MEN1 O00255 8/20 0.41
KMT2A Q03164 8/20 0.41
LMNA P02545 4/20 0.41
NPSR1 Q6W5P4 4/20 0.41
S1PR4 O95977 1/20 0.41
S1PR1 P21453 1/20 0.41
MAPK1 P28482 1/20 0.41
ALDH1A1 P00352 6/20 0.40
CYP1A2 P05177 5/20 0.40
CYP2D6 P10635 2/20 0.40
CYP1B1 Q16678 1/20 0.40
CYP2C19 P33261 3/20 0.39
GAA P10253 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP3A4 P08684 2/20 0.39
GPR55 Q9Y2T6 1/20 0.39
POLB P06746 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8824441 0.84 CYP1A2 (0.51) MAPTTP53THRBMEN1KMT2A
SCHEMBL8824439 0.84 CYP1A2 (0.51) MAPTTP53THRBMEN1KMT2A
SCHEMBL642421 0.80 MAPT (0.44) MAPTTP53THRBMEN1KMT2A
SCHEMBL642420 0.80 MAPT (0.44) MAPTTP53THRBMEN1KMT2A
SCHEMBL21950479 0.76 MEN1 (0.51) MAPTTP53THRBMEN1KMT2A
SCHEMBL11097979 0.74 POLB (0.66) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL22697045 0.74 POLB (0.66) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL11097975 0.74 POLB (0.66) MAPTMEN1KMT2ALMNANPSR1
SCHEMBL21950480 0.72 KMT2A (0.48) MAPTTP53THRBMEN1KMT2A
SCHEMBL20543707 0.71 MAPT (0.56) MAPTTP53THRBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119624-B2 Fused phenyl amido heterocyclic compounds PFIZER INC. (US) 2012-02-21 US disclosed
US-20110039821-A1 Fused Phenyl Amido Heterocyclic Compounds PFIZER INC 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039821-A1 Fused Phenyl Amido Heterocyclic Compounds GCK, GCKR, HK1 MAPT 3264/4885TP53 1900/4885THRB 975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.